| Literature DB >> 35669900 |
Shoko Yamashita1,2, Masaaki Nishi1, Kozo Yoshikawa1, Toshihiro Nakao1, Takuya Tokunaga1, Chie Takasu1, Hideya Kashihara1, Yuma Wada1, Toshiaki Yoshimoto1, Yosuke Iwakawa1, Takeshi Oya3, Koichi Tsuneyama2, Mitsuo Shimada1.
Abstract
Gastric carcinomas with lymphoid stroma (GCLS) are characterized by prominent stromal infiltration of lymphocyte and account for 1-4% of gastric cancers. Although, osteoclast-like giant cells (OGC) have been reported in some GCLS, OGCs in gastric tumors is exceedingly rare. A 60-year-old woman presented to our hospital after the finding of a positive fecal blood test during a routine medical check. Esophagogastroduodenoscopy revealed a Type 0-III + IIc tumor in the middle part of the gastric body. Biopsy revealed a poorly differentiated tumor and she was referred to our department. Early phase computed tomography showed thickening of the wall in the middle of the gastric body and enlargement of nearby lymph nodes. Laparoscopic total gastrectomy was performed. Pathological examination revealed a hamartomatous inverted polyp (HIP) in the submucosal layer with tub2-por1 tumor in the HIP. Prominent lymphocytic infiltration and OGCs were found around the tumor. Immunohistochemical analysis showed that the tumor cells were negative for EBER, MLH-1, and MSH2, 6. These findings suggest that this tumor was a non-microsatellite instability (MSI)-high GCLS without Epstein-Barr virus (EBV) infection. The patient's postoperative course was uneventful and she was discharged 11 days after surgery. She remains well 3 years after surgery.Entities:
Keywords: Gastric cancer; Gastric carcinoma with lymphoid stroma; Hamartomatous inverted polyp; Osteoclast-like giant cell
Year: 2022 PMID: 35669900 PMCID: PMC9163280 DOI: 10.1007/s13691-022-00547-w
Source DB: PubMed Journal: Int Cancer Conf J ISSN: 2192-3183